Global Med Technologies(R), Inc. Announces ARUP Laboratories - Becomes 20th Vein-to-Vein(R) Client
2005年9月22日 - 11:00PM
PRニュース・ワイアー (英語)
SafeTrace(R) and SafeTrace Tx(R)* Will Be Installed at Prominent
Utah Reference Laboratory and Centralized Transfusion Service
DENVER, Sept. 22 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R)
("Wyndgate"), a division of Global Med Technologies(R), Inc.
(OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"),
announced the signing of a contract with ARUP Laboratories for its
SafeTrace(R) donor management system and SafeTrace Tx(R) advanced
transfusion management system. ARUP Laboratories is a national
reference laboratory owned by the University of Utah. ARUP will use
SafeTrace and SafeTrace Tx to manage its blood donor center and
centralized transfusion service. Terms of the contract were not
disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ) Gloria
Pitt, Assistant Vice President and IT Manager at ARUP, said, "We
were in need of a software management system that could handle our
current volume, as well as grow with us to meet projected needs to
process more than 40,000 blood donations and more than 130,000
blood transfusion-related tests per year." Ms. Pitt continued, "We
were comfortable that SafeTrace and SafeTrace Tx could handle our
needs both now and in the future. In addition, the Centralized
Transfusion Service functionality and proven HL7 Interfaces in
SafeTrace Tx, as well as the Vein-to-Vein(R) link to SafeTrace,
were important features which helped drive our decision to move
forward with Wyndgate Technologies." Wm. Scott Dustin, Wyndgate's
Vice President of Sales and Marketing, stated, "Robust
functionality, interfaces to information systems, as well as
analyzers, and stable software applications are critical for large
and complex organizations such as ARUP Laboratories. Our SafeTrace
and SafeTrace Tx products are recognized leaders in these areas and
we are proud to add ARUP Laboratories to our growing customer
base." About ARUP Laboratories ARUP Laboratories is a national
clinical and anatomic pathology reference laboratory and an
enterprise of the University of Utah and its Department of
Pathology. With nearly 1,800 employees, ARUP offers in excess of
2,000 tests and test combinations, ranging from routine screening
tests to highly esoteric molecular and genetic assays, for patients
throughout the country. Rather than competing with its clients for
physician office business, ARUP chooses instead to support clients'
existing test menus by offering highly complex and unique tests,
with accompanying consultative support, to enhance their abilities
to provide local and regional laboratory services. ARUP's clients
include more than half of the nation's university teaching
hospitals and children's hospitals, as well as multi-hospital
groups, major commercial laboratories, group purchasing
organizations, military and government facilities, and major
clinics. In addition, ARUP is a worldwide leader in innovative
laboratory research and development, led by the efforts of the ARUP
Institute for Clinical and Experimental Pathology(TM). ARUP also
operates a Blood Services division which is the sole blood provider
to University of Utah Hospital, Huntsman Cancer Hospital, Primary
Children's Medical Center, and Shriners Hospital for Children,
representing approximately 25 percent of the blood transfused in
Utah. Further information on ARUP Laboratories can be obtained at
http://www.aruplab.com/. Contact Information: Ronald L. Weiss,
M.D., M.B.A. - President and COO, (801) 584-5188 About Global Med
Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health, medical information technology company,
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Saharan Africa. Together, the
SafeTrace donor management system and the SafeTrace Tx advanced
transfusion management system provide Vein-to-Vein tracking from
donor collection to patient transfusion. For more information about
Global Med's products and services, please call 800-WYNDGATE or
visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med
Technologies(R), Inc., +1-303-238-2000; or Investor Relations, John
Nesbett, or Jordan Silverstein, both of The Investor Relations
Group, +1-212-825-3210, for Global Med Technologies, Inc.; or
Ronald L. Weiss, M.D., M.B.A., President and COO of ARUP
Laboratories, +1-801-584-5188 Web site: http://www.wyndgate.com/
Web site: http://www.peoplemed.com/ Web site:
http://www.aruplab.com/ Web site: http://www.globalmedtech.com/
Copyright